The present study was undertaken to determine whether administration of adriamycin causes the depletion of riboflavin content . Rats received intraperitoneal injections of adriamycin (4mg per kg body weight) for 6 consecutive days. Urinary riboflavin excretion began to increase after 2 days of treatment with adriamycin. Erythrocyte FAD levels decreased gradually and plasma lipid peroxide contents increased markedly at the 6th day. The activity coefficient of erythrocyte glutathi one reductase showed a significant increase before the decrease of flavin content and the elevation of lipid peroxide level. Therefore, the value of this coefficient obtained from erythrocyte appears to be a reliable index of riboflavin deficiency, particularly during the early stage.
Adriamycin is a widely prescribed drug that is effective in the treatment of certain human malignancies. However, adriamycin produces a dose-dependent cardiotoxicity that restricts its clinical use in chemotherapy. We reported that intraperitoneal administration of adriamycin induces the depletion of flavin content in rat heart mitochondria (1) . The combination use of adriamycin with riboflavin was found to be effective in preventing heart mitochondrial disorders in rats treated with adriamycin (1) . Therefore, the depletion of riboflavin in tissues is considered to be closely related to the administration of adriamycin .
Besides the reports concerning adriamycin, a number of clinically used psy chotropic agents have been known to accelerate the depletion of tissue stores of riboflavin compounds (2, 3). Yagi et al. (4, 5) reported that administration of antibiotics also causes a deficiency of riboflavin.
In order to clarify the relationship between riboflavin depletion and adria mycin, the present paper discussed the alteration of erythrocyte flavin content in rats treated with adriamycin, along with its relation to the urinary excretion of riboflavin.
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MATERIALS AND METHODS
Adriamycin was obtained from Kyowa Hakko Kogyo (Tokyo) and dissolved in distilled water before use. Male Wistar rats received intraperitoneal injections of adriamycin (4mg per kg body weight) daily for 6 consecutive days, to induce an acute cardiotoxicity in a short period of time (6, 7) . Blood was obtained from rats at the 3rd, 5th and 7th day, from the cervical vein with a heparin-coated syringe (approximately 1ml each). Flavin derivatives in the erythrocytes were analyzed by high-pressure liquid chromatography [HPLC] on a Lichrosorb RP-2 column using 10% methanol and 10 mM NaH2PO4 as the mobile phase, by the method of Ohkawa and Ohishi (8) . Lipid peroxide content was determined by thiobarbituric acid acetic acid method and expressed as nmol malondialdehyde per 1ml plasma or mg protein (9) . Protein content was determined using biuret reaction (10) . The raw urine specimens were collected in a flask assembled with a metabolic cage. Spec imens obtained from animals having diarrhea were omitted from the present experiment. The quantitative analysis of flavin in urine was performed by applying the fluorometric method of Yagi (11) . The method was based on the fluorescence measurement of lumiflavin which is derived from riboflavin, FMN or FAD by photolysis in alkaline medium and is extracted with chloroform from acidified medium. To remove chloroform-soluble fluorescent substances in urine, urine was pretreated with chloroform until all the chloroform-soluble fluorescent substances were removed. After the preextraction, the photolysis was performed. In addition, chloroform extract from non-irradiated sample solution, was processed in parallel as blank (11) . All data were presented as mean value with standard deviation. Statistical significance was tested by Student's t-test. The criterion of significance was a p value of less than 0.05. RESULTS 
AND DISCUSSION
The time course of urinary riboflavin excretion of rats treated with adriamycin is shown in Fig. 1 . The urinary excretion began to increase rapidly after 2 days of intraperitoneal injection with adriamycin.
To find the blood level of riboflavin, erythrocyte riboflavin content was determined. As shown in Fig. 1 , adriamycin was administered for 6 days, and the total flavin content in the erythrocytes was decreased remarkably at the 6th day, following the increase of urinary excretion. Especially important is the decline of FAD content, as shown in Table 1 . However, adriamycin had no significant effect upon FMN and free riboflavin (FR) contents in the erythrocytes. As glutathione reductase requires FAD as its prosthetic group, glutathione reductase activity in erythrocytes was determined. Along with the depletion of total riboflavin in the erythrocytes, glutathione reductase activities fell to half at the 6th day, as shown in Table 1 , in parallel with the decrease of FAD content in the erythrocytes. The pressing the ratio of the enzyme activity in the presence of exogenous FAD to that in the absence of FAD in vitro. Significant increases in the activity coefficient were found in the erythrocytes obtained on the 4th and 6th day. Thus, the adriamycin administration produces changes in riboflavin homeostasis that are detectable by assays that are utilized to assess riboflavin deficiency.
As it is suggested that the deficiency of riboflavin brings about a decrease of (6) . Therefore, the effects of adriamycin on heart mitochndria were examined to determine the correlation of fiavin depletion in erytheocytes with that in the heart mitochondria.
As shown in Table  2 The following several possibilities may be considered. The adriamycin structure and the isoalloxazine ring of FAD may form an electron donor-acceptor com plex, or adriamycin may accelerate the riboflavin metabolism. In addition, adria mycin is known to convert to its semiquinone radical form, which leads to the production of a reactive oxygen species (12) . Therefore, riboflavin may be con sumed in the scavenging of free radical oxygen species produced by semiquinone adriamycin.
In conclusion, with respect to heart mitochondrial damages induced by adri amycin, it is worthy of notice that significant increases in the erythrocyte activity coefficient of glutathione reductase are detectable prior to the remarkable increase of serum and tissue lipid peroxide contents. The elevated activity coefficient appears to be a sensitive index of marginal riboflavin deficiency.
